AI driven human edited meeting Notes with health-quant team and https://pajr.in/ on 8/9/25, 10:00AM:
Meeting Overview:
Ecskin health-quant team: Skin irritation from the glucose monitoring device shows minimal impact, with 8-subject study indicating aloe vera's effectiveness, though long-term use may pose risks.
Phase two strategy favors a DIY approach by training school children to apply the paste; ethical clearance from review boards is essential before advancing to human trials.
Sensor development is nearing completion; decision required on whether to proceed with partial clinical validation or await full prototype.
Clinical trials will commence with blood sugar monitoring; cortisol measurement will follow once the full prototype is ready.
PaJR team rep: highlighted that mainstream validation requires 500+ participants, suggesting initial pilot studies with 30 samples for feasibility assessment.
Resource allocation should start conservatively with 1-2 dedicated personnel to gather initial data and build from day-to-day experiences.
Ethical clearance process must prioritize human trials with diabetic patients, as animal trials do not correlate as effectively for this device.
PaJR team rep said their current user driven patient monitoring system integrates energy inputs and outputs, enhancing data for device validation.
Health-Quant Team consists of 5 members, including 3 PhD students aiming for academic roles; resource constraints limit potential collaboration visits.
Plans to establish connections with health informatics professionals in Taiwan to explore local networking opportunities for project support using PaJR team rep's network there.
Publicly available full text around the tech:


No comments:
Post a Comment